Loading…

Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil

Vaccination against the hepatitis A virus (HAV) administered in two doses has been used effectively in universal child immunization programs in several countries. A single-dose vaccination was adopted in some low-income countries in an attempt to reduce costs without losing effectiveness. In 2014, s...

Full description

Saved in:
Bibliographic Details
Published in:The Brazilian journal of infectious diseases 2018-05, Vol.22 (3), p.166-170
Main Authors: Brito, Wagner Izidoro de, Alves-Junior, Eduardo Rodrigues, Oliveira, Rode Martinho de, Souto, Francisco José Dutra
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c560t-e22b045f9fc5b6aaceb0e62a81cffe0a83ac9a15638c85b24538cf46724bf2513
cites cdi_FETCH-LOGICAL-c560t-e22b045f9fc5b6aaceb0e62a81cffe0a83ac9a15638c85b24538cf46724bf2513
container_end_page 170
container_issue 3
container_start_page 166
container_title The Brazilian journal of infectious diseases
container_volume 22
creator Brito, Wagner Izidoro de
Alves-Junior, Eduardo Rodrigues
Oliveira, Rode Martinho de
Souto, Francisco José Dutra
description Vaccination against the hepatitis A virus (HAV) administered in two doses has been used effectively in universal child immunization programs in several countries. A single-dose vaccination was adopted in some low-income countries in an attempt to reduce costs without losing effectiveness. In 2014, single-dose universal vaccination was introduced in Brazil for children aged two years. Since such strategy is still not universally accepted, its efficacy should be compared to the two-dose strategy. To assess the humoral response after the single-dose HAV vaccination schedule, a cross-sectional study was conducted in Primavera do Leste, in Mato Grosso state, Central Brazil, including 265 children vaccinated through the National Immunization Program. Blood was collected by using a digital puncture and further applied to filter paper cards. Anti-HAV was detected in 218 out of 265 dried blood spots (DBS). Blood venous samples were collected from 34 out of 47 children who were not anti-HAV positive in DBS samples. Eighteen of them tested positive for anti-HAV, giving a final score of 93.6% (236/252) of seropositivity. In conclusion, this study demonstrated a high rate of anti-HAV positivity in the short term after single-dose hepatitis A vaccination in the population investigated. Moreover, the DBS was shown to be a reliable tool for detecting anti-HAV antibodies.
doi_str_mv 10.1016/j.bjid.2018.04.001
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2806dded5fd64002851d919b05211343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1413_86702018000300166</scielo_id><els_id>S141386701731036X</els_id><doaj_id>oai_doaj_org_article_2806dded5fd64002851d919b05211343</doaj_id><sourcerecordid>2031030176</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-e22b045f9fc5b6aaceb0e62a81cffe0a83ac9a15638c85b24538cf46724bf2513</originalsourceid><addsrcrecordid>eNp9Uk2P0zAQjRCI_YA_wAH5yKVh7NhuIiGk3YqFSitxAM6W40zaCWlc7KSI_fU4ZFmxF04ez7x58_w8WfaKQ86B67ddXnfU5AJ4mYPMAfiT7JzrdbmSRcWfpljyYlXqNZxlFzF2AEKBhOfZmah0KQsB59n37UAj2Z7hyfaTHckPzLdsGuiEIaY8HQ7pcrdUftK4Z5ZFGnY9ssZHZHZnaYgj2-MxYUaK7IqdKEyR0cA2OIwhkVwHe0f9i-xZa_uIL-_Py-zbzYevm0-r288ft5ur25VTGsYVClGDVG3VOlVrax3WgFrYkru2RbBlYV1ludJF6UpVC6lS0Eq9FrJuheLFZbZdeBtvO3MMdLDhl_GWzJ-EDztjw0iuRyNK0E2DjWobLZM_peJNxasalOC8kEXiyheu6Ah7bzo_hSGJN19mc81s7uw_ABTJf61Tw_ul4TjVB2zc4sAjFY8rA-3Nzp9MJYXSqkoEb-4Jgv8xYRzNgaLDvrcD-ikaAQVPw_h6niUWqAs-xoDtwxgOZl4R05l5Rcws0YA0SWJqev2vwIeWvzuRAO8WAKY_OhEGM799cNhQQDcmE-l__L8B3xrMAg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2031030176</pqid></control><display><type>article</type><title>Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil</title><source>PubMed Central Free</source><source>Elsevier ScienceDirect Journals</source><source>SciELO</source><creator>Brito, Wagner Izidoro de ; Alves-Junior, Eduardo Rodrigues ; Oliveira, Rode Martinho de ; Souto, Francisco José Dutra</creator><creatorcontrib>Brito, Wagner Izidoro de ; Alves-Junior, Eduardo Rodrigues ; Oliveira, Rode Martinho de ; Souto, Francisco José Dutra</creatorcontrib><description>Vaccination against the hepatitis A virus (HAV) administered in two doses has been used effectively in universal child immunization programs in several countries. A single-dose vaccination was adopted in some low-income countries in an attempt to reduce costs without losing effectiveness. In 2014, single-dose universal vaccination was introduced in Brazil for children aged two years. Since such strategy is still not universally accepted, its efficacy should be compared to the two-dose strategy. To assess the humoral response after the single-dose HAV vaccination schedule, a cross-sectional study was conducted in Primavera do Leste, in Mato Grosso state, Central Brazil, including 265 children vaccinated through the National Immunization Program. Blood was collected by using a digital puncture and further applied to filter paper cards. Anti-HAV was detected in 218 out of 265 dried blood spots (DBS). Blood venous samples were collected from 34 out of 47 children who were not anti-HAV positive in DBS samples. Eighteen of them tested positive for anti-HAV, giving a final score of 93.6% (236/252) of seropositivity. In conclusion, this study demonstrated a high rate of anti-HAV positivity in the short term after single-dose hepatitis A vaccination in the population investigated. Moreover, the DBS was shown to be a reliable tool for detecting anti-HAV antibodies.</description><identifier>ISSN: 1413-8670</identifier><identifier>ISSN: 1678-4391</identifier><identifier>EISSN: 1678-4391</identifier><identifier>DOI: 10.1016/j.bjid.2018.04.001</identifier><identifier>PMID: 29684320</identifier><language>eng</language><publisher>Brazil: Elsevier Editora Ltda</publisher><subject>Anti-HAV ; Brazil - epidemiology ; Child ; Dried Blood Spot Testing ; Female ; Hepatitis A - epidemiology ; Hepatitis A - prevention &amp; control ; Hepatitis A Antibodies - blood ; Hepatitis A vaccine ; Hepatitis A Vaccines - administration &amp; dosage ; Hepatitis A Vaccines - immunology ; Hepatitis A Virus, Human - immunology ; Humans ; Immunization programs ; Immunization Schedule ; Immunoenzyme Techniques ; INFECTIOUS DISEASES ; Logistic Models ; Male ; Mass Vaccination - methods ; Original ; Program Evaluation ; Retrospective Studies ; Seroepidemiologic Studies ; Single-dose schedule</subject><ispartof>The Brazilian journal of infectious diseases, 2018-05, Vol.22 (3), p.166-170</ispartof><rights>2018 Sociedade Brasileira de Infectologia</rights><rights>Copyright © 2018 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. All rights reserved.</rights><rights>2018 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. 2018 Sociedade Brasileira de Infectologia</rights><rights>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-e22b045f9fc5b6aaceb0e62a81cffe0a83ac9a15638c85b24538cf46724bf2513</citedby><cites>FETCH-LOGICAL-c560t-e22b045f9fc5b6aaceb0e62a81cffe0a83ac9a15638c85b24538cf46724bf2513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425659/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S141386701731036X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,24150,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29684320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brito, Wagner Izidoro de</creatorcontrib><creatorcontrib>Alves-Junior, Eduardo Rodrigues</creatorcontrib><creatorcontrib>Oliveira, Rode Martinho de</creatorcontrib><creatorcontrib>Souto, Francisco José Dutra</creatorcontrib><title>Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil</title><title>The Brazilian journal of infectious diseases</title><addtitle>Braz J Infect Dis</addtitle><description>Vaccination against the hepatitis A virus (HAV) administered in two doses has been used effectively in universal child immunization programs in several countries. A single-dose vaccination was adopted in some low-income countries in an attempt to reduce costs without losing effectiveness. In 2014, single-dose universal vaccination was introduced in Brazil for children aged two years. Since such strategy is still not universally accepted, its efficacy should be compared to the two-dose strategy. To assess the humoral response after the single-dose HAV vaccination schedule, a cross-sectional study was conducted in Primavera do Leste, in Mato Grosso state, Central Brazil, including 265 children vaccinated through the National Immunization Program. Blood was collected by using a digital puncture and further applied to filter paper cards. Anti-HAV was detected in 218 out of 265 dried blood spots (DBS). Blood venous samples were collected from 34 out of 47 children who were not anti-HAV positive in DBS samples. Eighteen of them tested positive for anti-HAV, giving a final score of 93.6% (236/252) of seropositivity. In conclusion, this study demonstrated a high rate of anti-HAV positivity in the short term after single-dose hepatitis A vaccination in the population investigated. Moreover, the DBS was shown to be a reliable tool for detecting anti-HAV antibodies.</description><subject>Anti-HAV</subject><subject>Brazil - epidemiology</subject><subject>Child</subject><subject>Dried Blood Spot Testing</subject><subject>Female</subject><subject>Hepatitis A - epidemiology</subject><subject>Hepatitis A - prevention &amp; control</subject><subject>Hepatitis A Antibodies - blood</subject><subject>Hepatitis A vaccine</subject><subject>Hepatitis A Vaccines - administration &amp; dosage</subject><subject>Hepatitis A Vaccines - immunology</subject><subject>Hepatitis A Virus, Human - immunology</subject><subject>Humans</subject><subject>Immunization programs</subject><subject>Immunization Schedule</subject><subject>Immunoenzyme Techniques</subject><subject>INFECTIOUS DISEASES</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Mass Vaccination - methods</subject><subject>Original</subject><subject>Program Evaluation</subject><subject>Retrospective Studies</subject><subject>Seroepidemiologic Studies</subject><subject>Single-dose schedule</subject><issn>1413-8670</issn><issn>1678-4391</issn><issn>1678-4391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9Uk2P0zAQjRCI_YA_wAH5yKVh7NhuIiGk3YqFSitxAM6W40zaCWlc7KSI_fU4ZFmxF04ez7x58_w8WfaKQ86B67ddXnfU5AJ4mYPMAfiT7JzrdbmSRcWfpljyYlXqNZxlFzF2AEKBhOfZmah0KQsB59n37UAj2Z7hyfaTHckPzLdsGuiEIaY8HQ7pcrdUftK4Z5ZFGnY9ssZHZHZnaYgj2-MxYUaK7IqdKEyR0cA2OIwhkVwHe0f9i-xZa_uIL-_Py-zbzYevm0-r288ft5ur25VTGsYVClGDVG3VOlVrax3WgFrYkru2RbBlYV1ludJF6UpVC6lS0Eq9FrJuheLFZbZdeBtvO3MMdLDhl_GWzJ-EDztjw0iuRyNK0E2DjWobLZM_peJNxasalOC8kEXiyheu6Ah7bzo_hSGJN19mc81s7uw_ABTJf61Tw_ul4TjVB2zc4sAjFY8rA-3Nzp9MJYXSqkoEb-4Jgv8xYRzNgaLDvrcD-ikaAQVPw_h6niUWqAs-xoDtwxgOZl4R05l5Rcws0YA0SWJqev2vwIeWvzuRAO8WAKY_OhEGM799cNhQQDcmE-l__L8B3xrMAg</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>Brito, Wagner Izidoro de</creator><creator>Alves-Junior, Eduardo Rodrigues</creator><creator>Oliveira, Rode Martinho de</creator><creator>Souto, Francisco José Dutra</creator><general>Elsevier Editora Ltda</general><general>Elsevier</general><general>Brazilian Society of Infectious Diseases</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>GPN</scope><scope>DOA</scope></search><sort><creationdate>20180501</creationdate><title>Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil</title><author>Brito, Wagner Izidoro de ; Alves-Junior, Eduardo Rodrigues ; Oliveira, Rode Martinho de ; Souto, Francisco José Dutra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-e22b045f9fc5b6aaceb0e62a81cffe0a83ac9a15638c85b24538cf46724bf2513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anti-HAV</topic><topic>Brazil - epidemiology</topic><topic>Child</topic><topic>Dried Blood Spot Testing</topic><topic>Female</topic><topic>Hepatitis A - epidemiology</topic><topic>Hepatitis A - prevention &amp; control</topic><topic>Hepatitis A Antibodies - blood</topic><topic>Hepatitis A vaccine</topic><topic>Hepatitis A Vaccines - administration &amp; dosage</topic><topic>Hepatitis A Vaccines - immunology</topic><topic>Hepatitis A Virus, Human - immunology</topic><topic>Humans</topic><topic>Immunization programs</topic><topic>Immunization Schedule</topic><topic>Immunoenzyme Techniques</topic><topic>INFECTIOUS DISEASES</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Mass Vaccination - methods</topic><topic>Original</topic><topic>Program Evaluation</topic><topic>Retrospective Studies</topic><topic>Seroepidemiologic Studies</topic><topic>Single-dose schedule</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brito, Wagner Izidoro de</creatorcontrib><creatorcontrib>Alves-Junior, Eduardo Rodrigues</creatorcontrib><creatorcontrib>Oliveira, Rode Martinho de</creatorcontrib><creatorcontrib>Souto, Francisco José Dutra</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SciELO</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>The Brazilian journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brito, Wagner Izidoro de</au><au>Alves-Junior, Eduardo Rodrigues</au><au>Oliveira, Rode Martinho de</au><au>Souto, Francisco José Dutra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil</atitle><jtitle>The Brazilian journal of infectious diseases</jtitle><addtitle>Braz J Infect Dis</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>22</volume><issue>3</issue><spage>166</spage><epage>170</epage><pages>166-170</pages><issn>1413-8670</issn><issn>1678-4391</issn><eissn>1678-4391</eissn><abstract>Vaccination against the hepatitis A virus (HAV) administered in two doses has been used effectively in universal child immunization programs in several countries. A single-dose vaccination was adopted in some low-income countries in an attempt to reduce costs without losing effectiveness. In 2014, single-dose universal vaccination was introduced in Brazil for children aged two years. Since such strategy is still not universally accepted, its efficacy should be compared to the two-dose strategy. To assess the humoral response after the single-dose HAV vaccination schedule, a cross-sectional study was conducted in Primavera do Leste, in Mato Grosso state, Central Brazil, including 265 children vaccinated through the National Immunization Program. Blood was collected by using a digital puncture and further applied to filter paper cards. Anti-HAV was detected in 218 out of 265 dried blood spots (DBS). Blood venous samples were collected from 34 out of 47 children who were not anti-HAV positive in DBS samples. Eighteen of them tested positive for anti-HAV, giving a final score of 93.6% (236/252) of seropositivity. In conclusion, this study demonstrated a high rate of anti-HAV positivity in the short term after single-dose hepatitis A vaccination in the population investigated. Moreover, the DBS was shown to be a reliable tool for detecting anti-HAV antibodies.</abstract><cop>Brazil</cop><pub>Elsevier Editora Ltda</pub><pmid>29684320</pmid><doi>10.1016/j.bjid.2018.04.001</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1413-8670
ispartof The Brazilian journal of infectious diseases, 2018-05, Vol.22 (3), p.166-170
issn 1413-8670
1678-4391
1678-4391
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2806dded5fd64002851d919b05211343
source PubMed Central Free; Elsevier ScienceDirect Journals; SciELO
subjects Anti-HAV
Brazil - epidemiology
Child
Dried Blood Spot Testing
Female
Hepatitis A - epidemiology
Hepatitis A - prevention & control
Hepatitis A Antibodies - blood
Hepatitis A vaccine
Hepatitis A Vaccines - administration & dosage
Hepatitis A Vaccines - immunology
Hepatitis A Virus, Human - immunology
Humans
Immunization programs
Immunization Schedule
Immunoenzyme Techniques
INFECTIOUS DISEASES
Logistic Models
Male
Mass Vaccination - methods
Original
Program Evaluation
Retrospective Studies
Seroepidemiologic Studies
Single-dose schedule
title Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A48%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initial%20evaluation%20of%20universal%20immunization%20with%20a%20single%20dose%20against%20hepatitis%20A%20virus%20in%20Central%20Brazil&rft.jtitle=The%20Brazilian%20journal%20of%20infectious%20diseases&rft.au=Brito,%20Wagner%20Izidoro%20de&rft.date=2018-05-01&rft.volume=22&rft.issue=3&rft.spage=166&rft.epage=170&rft.pages=166-170&rft.issn=1413-8670&rft.eissn=1678-4391&rft_id=info:doi/10.1016/j.bjid.2018.04.001&rft_dat=%3Cproquest_doaj_%3E2031030176%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c560t-e22b045f9fc5b6aaceb0e62a81cffe0a83ac9a15638c85b24538cf46724bf2513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2031030176&rft_id=info:pmid/29684320&rft_scielo_id=S1413_86702018000300166&rfr_iscdi=true